|
|
Clinical efficacy of intratracheal instillation of Budesonide combined with pulmonary surfactant in the treatment of meconium aspiration syndrome |
WANG Li WANG Qiuyue▲ |
Department of Pediatrics, General Hospital of China Aviation of China Medical University, Beijing 100012, China |
|
|
Abstract Objective To study the clinical efficacy of Budesonide combined with pulmonary surfactant (PS) in neonates with meconium aspiration syndrome (MAS). Methods A total of 98 neonates with MAS in General Hospital of China Aviation of China Medical University from May 2014 to May 2017 were enrolled and divided into the control group (n = 49) and the treatment group (n = 49) by random number table. The control group was treated with PS dropping into trachea, the treatment group was treated with Budesonide combined with PS dropping into trachea, both were intratracheal drops. The clinical efficacy of the two groups; the PaO2, PaCO2 and TcSaO2 of the two groups at the times of before treatment (0 h), 12 h after treatment, 24 h after treatment and 48 h after treatment; the hospital stays, oxygen exposure time and mechanical ventilation time of the two groups were recorded and compared. The adverse reactions rates of the two groups after treatment were compared. Results The total efficacy rate of the treatment group was 93.88% (46/49), was higher than that of the control group [75.51% (37/49)], the difference was statistically significant (P < 0.05). The PaO2, PaCO2 and TcSaO2 of the two groups at each time poinits after treatment were significantly better than at the times of 0 h (P < 0.05), as the extension of time, the PaO2 and TcSaO2 gradually increased, the PaCO2 gradually reduced, and the PaO2, PaCO2 and TcSaO2 of the treatment group at each time points after treatment were significantly better than that of the control group, the differences were statistically significant (P < 0.01). The hospital stays, oxygen exposure time and mechanical ventilation time of the treatment group were significantly shorter than those of the control group, the differences were statistically significant (P < 0.01). After treatment, the adverse reaction rate of the treatment group was significantly lower than that of the control group, the difference was statistically significant (P < 0.05). Conclusion Budesonide combined with PS in the treatment of neonates with MAS has a good efficacy and low adverse reactions, can reduce the treatment time, improve the oxygenation function, it is worth popularizing in clinical application.
|
|
|
|
|
[1] 陈梅芳.胎粪吸入综合征的临床研究进展[J].临床医学,2016,36(6):126-128.
[2] 李燕妮,徐东红.胎粪吸入综合征的诊治研究进展[J].临床医学,2014,34(3):116-117.
[3] 尹茜,苏娜,陈小红,等.氨溴索治疗新生儿胎粪吸入综合征的系统评价研究[J].中国药学杂志,2012,47(10):776-781.
[4] 王六超,农绍汉.新生儿胎粪吸入综合征的治疗进展[J].医学综述,2014,20(22):4160-4162.
[5] 罗菲菲,杨迪元,陈攀,等.肺表面活性物质治疗新生儿胎粪吸入综合征临床疗效的meta分析[J].中国当代儿科杂志,2012,14(6):413-417.
[6] 夏耀方,刘翠青.外源性肺泡表面活性物质对胎粪吸入综合征患儿肺功能及血管内皮生长因子的影响[J].中国实用儿科杂志,2013,28(1):31-34.
[7] 杨迪元,沈莉荣,于爱真,等.糖皮质激素治疗胎粪吸入综合征疗效和安全性的Meta分析[J].中国循证儿科杂志,2011,6(2):126-134.
[8] 邵肖梅,叶鸿瑁,邱小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:398-401.
[9] ACoRN编委会.重危新生儿的急症监护[M].杭州:浙江大学出版社,2009:1-21.
[10] 虞人杰,徐小静.胎粪吸入综合征发病机制及治疗[J].中国新生儿科杂志,2011,26(5):359-360.
[11] 陶龙章.肺表面活性物质治疗新生儿胎粪吸入综合征42例的疗效分析[J].中外医疗,2011,30(20):15-17.
[12] 郑秦,邓春.胎粪吸入综合征治疗进展[J].儿科药学杂志,2016,22(5):58-61.
[13] 宋桂玲.肺表面活性物质对新生儿重症胎粪吸入综合征炎症反应及氧合功能的影响[J].临床和实验医学杂志,2016,15(17):1727-1730.
[14] 方锦平,卢小蕴,夏巧湘.气管内不同肺表面活性物质用药方案对重症胎粪吸入综合征患儿肺氧合功能指标、有创机械通气时间及并发症风险的影响[J].现代实用医学,2016,28(12):1611-1612.
[15] 邓黎静,彭华保,龚晓琴.布地奈德联合肺泡表面活性物质气管内滴入治疗早产儿重症呼吸窘迫综合症的疗效研究[J].中南医学科学杂志,2018,46(1):91-94.
[16] 施弦,郁峰.布地奈德联合孟鲁司特对支气管哮喘患儿炎性因子及免疫功能的影响[J].中国医药,2018,13(1):55-58.
[17] 张瑜丹.新生儿胎粪吸入综合征采用布地奈德雾化吸入治疗效果观察[J].基层医学论坛,2017,21(31):4311-4312.
[18] 李红菊,杜淑珍.布地奈德联合特布他林对哮喘急性期的治疗效果观察[J].中国医药,2017,12(3):347-351.
[19] 谭秀贞,吴时光,张建华,等.猪肺表面活性物质联合布地奈德混悬液气管内滴入治疗新生儿胎粪吸入综合征的疗效观察[J].中国当代儿科杂志,2016,18(12):1237-1241.
[20] 郭晓燕,车晓晴,张海霞.常规单剂量肺表面活性物质治疗重症胎粪吸入综合征患儿的疗效分析[J].中国继续医学教育,2015,7(33):172-173.
[21] 陈小燕,陈观伟,罗惠文,等.肺表面活性物质治疗对重症胎粪吸入综合征患儿氧合功能的影响[J].中国社区医师:医学专业,2013,15(9):162-163.
[22] 潘静,陈名武,倪文泉,等.肺表面活性物质联合布地奈德预防极低出生体重儿支气管肺发育不良的疗效观察[J].中国当代儿科杂志,2017,19(2):137-141. |
|
|
|